Our findings suggest that IGFBP-3 inhibits the adhesion of both HNSCC cells and HUVECs to the ECM at least in part by negatively regulating the expression of integrin β4 in an IGF-dependent and IGF-independent manner. The gene discussed is IGF1; the disease is head and neck squamous cell carcinoma.